120 related articles for article (PubMed ID: 11771739)
1. Functional genomics of Down syndrome: a multidisciplinary approach.
Dierssen M; Martí E; Pucharcós C; Fotaki V; Altafaj X; Casas K; Solans A; Arbonés ML; Fillat C; Estivill X
J Neural Transm Suppl; 2001; (61):131-48. PubMed ID: 11771739
[TBL] [Abstract][Full Text] [Related]
2. Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1.
Park J; Oh Y; Chung KC
BMB Rep; 2009 Jan; 42(1):6-15. PubMed ID: 19192387
[TBL] [Abstract][Full Text] [Related]
3. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
Kurabayashi N; Sanada K
Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
[TBL] [Abstract][Full Text] [Related]
4. Down syndrome and the genes of human chromosome 21: current knowledge and future potentials. Report on the Expert workshop on the biology of chromosome 21 genes: towards gene-phenotype correlations in Down syndrome. Washington D.C., September 28-October 1, 2007.
Pritchard M; Reeves RH; Dierssen M; Patterson D; Gardiner KJ
Cytogenet Genome Res; 2008; 121(1):67-77. PubMed ID: 18544929
[TBL] [Abstract][Full Text] [Related]
5. Machine learning methods predict locomotor response to MK-801 in mouse models of down syndrome.
Nguyen CD; Costa AC; Cios KJ; Gardiner KJ
J Neurogenet; 2011 Mar; 25(1-2):40-51. PubMed ID: 21391779
[TBL] [Abstract][Full Text] [Related]
6. Murine models for Down syndrome.
Dierssen M; Fillat C; Crnic L; Arbonés M; Flórez J; Estivill X
Physiol Behav; 2001 Aug; 73(5):859-71. PubMed ID: 11566219
[TBL] [Abstract][Full Text] [Related]
7. Cooperation to amplify gene-dosage-imbalance effects.
de la Luna S; Estivill X
Trends Mol Med; 2006 Oct; 12(10):451-4. PubMed ID: 16919501
[TBL] [Abstract][Full Text] [Related]
8. Mouse models of Down syndrome: gene content and consequences.
Gupta M; Dhanasekaran AR; Gardiner KJ
Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
[TBL] [Abstract][Full Text] [Related]
9. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype correlation for congenital heart disease in Down syndrome through analysis of partial trisomy 21 cases.
Pelleri MC; Gennari E; Locatelli C; Piovesan A; Caracausi M; Antonaros F; Rocca A; Donati CM; Conti L; Strippoli P; Seri M; Vitale L; Cocchi G
Genomics; 2017 Oct; 109(5-6):391-400. PubMed ID: 28648597
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations of the deletion of Down syndrome critical region including DYRK1A and KCNJ6.
Yamamoto T; Shimojima K; Nishizawa T; Matsuo M; Ito M; Imai K
Am J Med Genet A; 2011 Jan; 155A(1):113-9. PubMed ID: 21204217
[TBL] [Abstract][Full Text] [Related]
12. Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome.
Patel A; Rees SD; Kelly MA; Bain SC; Barnett AH; Thalitaya D; Prasher VP
Neurosci Lett; 2011 Jan; 487(2):144-8. PubMed ID: 20946940
[TBL] [Abstract][Full Text] [Related]
13. Commonality in Down and fetal alcohol syndromes.
Solzak JP; Liang Y; Zhou FC; Roper RJ
Birth Defects Res A Clin Mol Teratol; 2013 Apr; 97(4):187-97. PubMed ID: 23554291
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
[TBL] [Abstract][Full Text] [Related]
15. Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression.
Lu J; Mccarter M; Lian G; Esposito G; Capoccia E; Delli-Bovi LC; Hecht J; Sheen V
Hum Mol Genet; 2016 May; 25(9):1714-27. PubMed ID: 26911678
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.
Izzo A; Mollo N; Nitti M; Paladino S; Calì G; Genesio R; Bonfiglio F; Cicatiello R; Barbato M; Sarnataro V; Conti A; Nitsch L
Mol Med; 2018 Mar; 24(1):2. PubMed ID: 30134785
[TBL] [Abstract][Full Text] [Related]
17. Down syndrome offers fresh clues to angiogenesis.
Rowan K
J Natl Cancer Inst; 2009 Sep; 101(17):1170-1. PubMed ID: 19706624
[No Abstract] [Full Text] [Related]
18. A patient with Down syndrome with a de novo derivative chromosome 21.
Cetin Z; Yakut S; Mihci E; Manguoglu AE; Berker S; Keser I; Luleci G
Gene; 2012 Oct; 507(2):159-64. PubMed ID: 22827956
[TBL] [Abstract][Full Text] [Related]
19. Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome.
Laguna A; Barallobre MJ; Marchena MÁ; Mateus C; Ramírez E; Martínez-Cue C; Delabar JM; Castelo-Branco M; de la Villa P; Arbonés ML
Hum Mol Genet; 2013 Jul; 22(14):2775-84. PubMed ID: 23512985
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration.
Branchi I; Bichler Z; Minghetti L; Delabar JM; Malchiodi-Albedi F; Gonzalez MC; Chettouh Z; Nicolini A; Chabert C; Smith DJ; Rubin EM; Migliore-Samour D; Alleva E
J Neuropathol Exp Neurol; 2004 May; 63(5):429-40. PubMed ID: 15198122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
